Filter by:
Filter by:
Uncategorized
Securities class actions against life-sciences sector double in 2014
There has been a recent increase in securities class actions filed against life-sciences companies, with 39 cases filed in 2014 compared...
Uncategorized
Former BNY Mellon Executive and Vice Chairman Joins Financial Recovery Technologies as Senior Advisor
James Palermo brings to FRT over 30 years of financial industry experience in the custodial banking space Financial Recovery...
Uncategorized
Pfizer settlement proves cases against large caps do exist
In late January, Pfizer agreed to settle a class action suit to the tune of $400 million despite a recent Cornerstone Research report...

Keep up to date with FRT

Subscribe to our quarterly newsletter for updates on industry news, developments related to global class actions and antitrust opportunities – right in your inbox.
Subscribe
Uncategorized
Peaks and valleys of class actions: 2014 in review
Last year saw highs and lows in the securities class actions arena. The number of class actions filed in federal court remained steady...
Uncategorized
Understanding different types of securities class actions
Not all securities class actions are created equally. They originate in many different venues and various state and federal laws are...
Uncategorized
Motions to dismiss filed in 90% of securities class actions
Motions to dismiss are filed in over 90% of securities class actions and have close to a 50% success rate. When motions to dismiss are...